Formulary Digital Edition December 2010

News
Article

Focus on 2010: A year of novel pharmacologic agents in review; Azilsartan: A next-generation angiotensin II receptor blocker for the treatment of hypertension; Agents in late-stage development for the treatment of eye diseases

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Medication Prior Authorization Biggest Daily Challenge for 1 in 5 Prescribers, Survey Says

Logan Lutton
August 12th 2025
Article

Read More

FDA Approves First Treatment for Chronic Inflammatory Lung Condition

FDA Approves First Treatment for Chronic Inflammatory Lung Condition

Denise Myshko
August 12th 2025
Article

Read More

FDA Approves Ajovy for Childhood Migraine Prevention

FDA Approves Ajovy for Childhood Migraine Prevention

Logan Lutton
August 12th 2025
Article

Read More

ZAKARIYAE-stock@adobe.com

FDA Grants Accelerated Approval For Targeted Drug for Rare Brain Tumor

Denise Myshko
August 12th 2025
Article

Read More

kitsawet-stock@adobe.com

Valneva Updates Safety Label of Chikungunya Virus Vaccine

Denise Myshko
August 12th 2025
Article

Read More

FDA Approves Presbyopia Treatment, VIZZ

FDA Approves Presbyopia Treatment, VIZZ

Logan Lutton
August 12th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.